Reflow Medical

Executive Summary

Reflow Medical is a privately held cardiovascular device company based in San Clemente, California. Founded in 2015, the company develops physician-inspired solutions for unmet clinical needs through a collaborative innovation model that pairs engineers directly with clinicians. While specific product details are not publicly disclosed, Reflow Medical's focus on iterative, data-backed device development positions it to address significant gaps in cardiovascular care. As a private entity with no disclosed funding or commercial products, the company remains in early stages, but its physician-driven approach and targeted therapeutic area suggest potential for meaningful impact. Key upcoming catalysts include potential FDA clearance for a lead device, initiation of a pivotal clinical trial, or a Series A/B financing round to advance its pipeline.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) Clearance for Lead Peripheral Device55% success
• H2 2026Series A Financing Round60% success
• Q4 2026First-in-Human Clinical Trial Initiation50% success